Fused imidazole derivatives used as IL-17 inhibitors

MA51610AUndetermined Publication Date: 2021-04-21UCB BIOPHARMA SPRL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA51610
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-12-11
Filing Date
2019-01-10
Publication Date
2021-04-21
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.